Literature DB >> 25270155

Hepatocellular carcinoma in a patient with chronic lymphocytic leukaemia involving the liver.

Chika Ezigbo1, Alexander M Sy1, Andrea Popescu-Martinez2, Noella Boma1, Nora V Bergasa3.   

Abstract

A relationship between hepatocellular carcinoma and chronic lymphocytic leukaemia has been reported. This is a case of a 75-year-old woman with stable chronic lymphocytic leukaemia, not on treatment with an increased activity of serum alkaline phosphatase and negative liver disease work up. A liver biopsy revealed leukaemic infiltration without evidence of cirrhosis or fatty liver. Four years later, she presented with a rapidly progressive liver mass which was diagnosed as hepatocellular carcinoma histologically. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Year:  2014        PMID： 25270155      PMCID： PMC4180543          DOI： 10.1136/bcr-2014-205634

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  6 in total

1.  Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

Authors:  Li Liu; Yichen Cao; Charles Chen; Xiaomei Zhang; Angela McNabola; Dean Wilkie; Scott Wilhelm; Mark Lynch; Christopher Carter
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

2.  Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors.

Authors:  M Di Stasi; G Sbolli; F Fornari; L Cavanna; S Rossi; E Buscarini; G Civardi; D Vallisa; R Berté; L Buscarini
Journal:  Oncology       Date:  1994 Sep-Oct       Impact factor: 2.935

Review 3.  State of the art of the therapeutic perspective of sorafenib against hematological malignancies.

Authors:  G Zauli; R Voltan; V Tisato; P Secchiero
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

4.  Concomitant hepatocellular carcinoma and non-Hodgkin's lymphoma in a patient with nodular regenerative hyperplasia.

Authors:  Tatsuki R Kataoka; Yoshitane Tsukamoto; Naoko Kanazawa; Tadahiro Izumi; Nobuhisa Awata; Yasuko Nishizawa; Masahiko Ohsawa; Shingo Ishiguro
Journal:  Pathol Int       Date:  2006-05       Impact factor: 2.534

5.  Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy.

Authors:  Marta Muzio; Benedetta Apollonio; Cristina Scielzo; Michela Frenquelli; Irene Vandoni; Vassiliki Boussiotis; Federico Caligaris-Cappio; Paolo Ghia
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

6.  Second primary cancers following non-Hodgkin's lymphoma in Japan: increased risk of hepatocellular carcinoma.

Authors:  H Tanaka; H Tsukuma; H Teshima; W Ajiki; Y Koyama; N Kinoshita; T Masaoka; A Oshima
Journal:  Jpn J Cancer Res       Date:  1997-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.